Basic Medical Theory Research

[1] 李盛,黄茜,陈敏.雄激素性脱发的发病机制与激光治疗[J].激光生物学报,2016,25(02):107-111.
[2] Stefanie H,K A K ,Nadine F , et al.Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology.[J].The Journal of investigative dermatology,2013,133(6):1489-96.
[3] 孙建林,吕新翔.雄激素性脱发的发病机制与治疗进展[J].内蒙古医科大学学报,2020,42(01):106-108+112.
[4] 杨堃,付聪,凌佳琦,等.A型肉毒毒素治疗雄激素性脱发的机制及研究进展[J].中国美容整形外科杂志,2022,33(01):23-25.
[5] Maher SA,Ismail NA,Toraih EA,etal.Hair Follicle-Relat ed MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia:A Cross-Sectional Analysis. Biomol ecules.2022;12(5):
[6] 刘琴月.雄激素性脱发患病影响因素分析[D].华北理工大学,2022.
[7] Kaliyadan F, Nambiar A,Vijayaraghavan S. Androgenetic alopecia:an update. Indian J DdermatolVenereolLeprol. 2013; 79(5):613.doi:10.4103/0378-6323.116730.
[8] MessengerAG,RundegrenJ.Minoxidil:mechanism so facti on on hair growth.Br JDermatol.2004;150(2):186-94.
[9] 吴巍,赵宏伟.雄激素性脱发药物治疗及新药研究进展[J].组织工程与重建外科,2021,17(05):445-449.
[10] Ruiming H ,Feng X ,Youyu S , et al.Combined treatment with oral finasteride and topical minoxidil in male androge netic alopecia: a randomized and comparative study in Chinese patients.[J].Dermatologic therapy,2015,28(5):303-8.
[11] A T,M B P,M S. Evaluation of sexual function in subj ects taking finasteride for the treatment of androgenetic alopecia.[J]. Journal of the European Academy of Dermatology and Venereology:JEADV,2001,15(5).
[12] 吴大兴,吴丽峰.激光疗法在雄激素性脱发中的应用[J].中国麻风皮肤病杂志,2020,36(04):249-252.
[13] T.Arif,K.Dorjay,M.Adil,M.SamiDutasteride in androgen etic alopecia:an update Curr ClinPharmacol,12(2017),pp.3135,10.2174/1574884712666170310111125.
[14] Ntshingila S,Oputu O,Arowolo A T,etal.Androgenetic alopecia:An update[J].JAAD international,2023,13:150-158.
[15] S H ,R D N ,F F B , et al.No genetic support for a contribution of prostaglandins to the aetiology of androge netic alopecia.[J].The British journal of dermatology,2013,169(1):222-4.
[16] 韦菊梅.盐酸左西替利嗪对人毛乳头细胞生长影响的初步研究[D].广西医科大学,2019.
[17] A R ,D C ,C M F , et al.A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia.[J].The Journal of dermatological treatment,2018,29 (2):149-151.
[18] Delaram M H ,Aniseh S ,Somayeh N , et al.Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.[J].Journal of pharmacy & pharmaceutical sciences:a publication of the Canadian Society for Pharmace utical Sciences, Societe canadienne des sciences pharmaceuti ques,2021,24191-199.
[19] Stevens J,Khetarpal S.Platelet-rich plasma for andro genetic alopecia: A review of the literature and proposed treatment protocol[J].International Journal of Women's Derma tology,2019,5(1):46-51.
[20] Castro M F ,Grassi A S ,Rodrigo G , et al.Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases.[J].Aesthetic plastic surgery,2004,28(6):441-4.
[21] J B F,Marvin S. Treatment of male pattern baldness with botulinum toxin: a pilot study.[J]. Plastic and reconstr uctive surgery,2010,126(5).
[22] 章晾.肉毒毒素注射联合中胚层疗法治疗雄激素性脱发[J].中国医疗美容,2018,8(06):12-14.
[23] 崔晶,金珊,南美兰,等.A型肉毒素下调UVB诱导的HaCaT细胞炎症因子的表达[J].中国皮肤性病学杂志,2019,33(10):1121-1124.
[24] Hussein RS, Dayel SB, Abahussein O. Botulinum Toxin A for Hair Loss Treatment: A Systematic Review of Efficacy, Safety, and Future Directions. JPRAS open.2023 Sep 21.
[25] 李翔英,廉翠红,陆原.低能量激光联合非那雄胺治疗雄激素性脱发的临床研究[J].中国医疗美容,2018,8(02):36-38.
[26] Huang W ,Foster A J ,Rogachefsky S A .Pharmacology of botulinum toxin[J].Journal of the American Academy of Derma tology,2000,43(2):249-259.